[361]
Natural History of Early, Localized Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
prostate
cancer
“Everything You Need to Know About Prostate Cancer : Basic Research, Causes, Diagnosis, and Treatment”
Donald Vander Griend Ph.D.
University of Chicago Urology Research Laboratory
University of Chicago
2005 Huggins Lectureship
Lectures on the Internet
Lectures and information are posted on the Ben May Institute for Cancer Research Website
URL:
http://ben-may.bsd.uchicago.edu/bmi/presentations/3rd/index.html
Lecture Outline
Jan 15 - The Problem, The Prostate , and The Man
TODAY - What is Cancer ?
Jan 29 - The Causes of Prostate Cancer
Feb 5 - Diagnosing Prostate Cancer
Feb 12 - Treating Prostate Cancer
Feb 19 - Prostate ...
[362]
Waiting Time in Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
prostate
cancer
“Everything You Need to Know About Prostate Cancer : Basic Research, Causes, Diagnosis, and Treatment”
Donald Vander Griend Ph.D.
University of Chicago Urology Research Laboratory
University of Chicago
2005 Huggins Lectureship
Lectures on the Internet
Lectures and information are posted on the Ben May Institute for Cancer Research Website
URL:
http://ben-may.bsd.uchicago.edu/bmi/presentations/3rd/index.html
Lecture Outline
Jan 15 - The Problem, The Prostate , and The Man
TODAY - What is Cancer ?
Jan 29 - The Causes of Prostate Cancer
Feb 5 - Diagnosing Prostate Cancer
Feb 12 - Treating Prostate Cancer
Feb 19 - Prostate ...
[363]
PSA Kinetics and Risk of Death From Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
prostate
cancer
“Everything You Need to Know About Prostate Cancer : Basic Research, Causes, Diagnosis, and Treatment”
Donald Vander Griend Ph.D.
University of Chicago Urology Research Laboratory
University of Chicago
2005 Huggins Lectureship
Lectures on the Internet
Lectures and information are posted on the Ben May Institute for Cancer Research Website
URL:
http://ben-may.bsd.uchicago.edu/bmi/presentations/3rd/index.html
Lecture Outline
Jan 15 - The Problem, The Prostate , and The Man
TODAY - What is Cancer ?
Jan 29 - The Causes of Prostate Cancer
Feb 5 - Diagnosing Prostate Cancer
Feb 12 - Treating Prostate Cancer
Feb 19 - Prostate ...
[364]
091202 Surgery and the Reduction of Mortality from Prostate Cancer
From [content.nejm.org] Last viewed: 07.09.2006
NEWS RELEASE
Embargoed until 1100hrs (Central European Summer Time), Tuesday 11 July 2006
First European Consensus Published on the
Chemoprevention of Prostate Cancer
This week sees publication by the European Association of Urology (EAU) of the first European
consensus recommendations on the role of the selective 5-alpha reductase inhibitor, finasteride
in the prevention of prostate cancer
1
. The Consensus addresses the clinical implications of the
PCPT ( Prostate Cancer Prevention Trial), published in the New England Journal of Medicine
2
,
which reported that finasteride reduced the risk of developing prostate cancer by 25%.
Currently, finasteride is one of the principal treatments for men with benign prostatic hyperplasia
(BPH). Publication, also in the NEJM , of the MTOPS (Medical Treatment of Prostatic Symptoms)
Study
3 ...
[365]
Mechanisms of Androgen-Refractory Prostate Cancer
From [content.nejm.org] Last viewed: 07.09.2006
NEWS RELEASE
Embargoed until 1100hrs (Central European Summer Time), Tuesday 11 July 2006
First European Consensus Published on the
Chemoprevention of Prostate Cancer
This week sees publication by the European Association of Urology (EAU) of the first European
consensus recommendations on the role of the selective 5-alpha reductase inhibitor, finasteride
in the prevention of prostate cancer
1
. The Consensus addresses the clinical implications of the
PCPT ( Prostate Cancer Prevention Trial), published in the New England Journal of Medicine
2
,
which reported that finasteride reduced the risk of developing prostate cancer by 25%.
Currently, finasteride is one of the principal treatments for men with benign prostatic hyperplasia
(BPH). Publication, also in the NEJM , of the MTOPS (Medical Treatment of Prostatic Symptoms)
Study
3 ...
[366]
Estrogen Receptor b in Prostate Cancer
From [content.nejm.org] Last viewed: 07.09.2006
NEWS RELEASE
Embargoed until 1100hrs (Central European Summer Time), Tuesday 11 July 2006
First European Consensus Published on the
Chemoprevention of Prostate Cancer
This week sees publication by the European Association of Urology (EAU) of the first European
consensus recommendations on the role of the selective 5-alpha reductase inhibitor, finasteride
in the prevention of prostate cancer
1
. The Consensus addresses the clinical implications of the
PCPT ( Prostate Cancer Prevention Trial), published in the New England Journal of Medicine
2
,
which reported that finasteride reduced the risk of developing prostate cancer by 25%.
Currently, finasteride is one of the principal treatments for men with benign prostatic hyperplasia
(BPH). Publication, also in the NEJM , of the MTOPS (Medical Treatment of Prostatic Symptoms)
Study
3 ...
[367]
Re: Serum Proteomic Patterns for Detection of Prostate Cancer
[35,8 KB]
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[368]
Prostate Cancer Genetics Research Picks Up Pace
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[369]
Hormones and Prostate Cancer: Where Do We Go From Here?
[342,9 KB]
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[370]
Are Dietary Fatand Vasectomy Risk Factors for Prostate Cancer?
[339,6 KB]
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[371]
References Note Re: Prostate Cancer and the Androgen Receptor
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[372]
Preoperative Nomogram Predicting the 10-Year Probability of ...
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[373]
Gene Fusion Found in Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[374]
New Markers May Help Predict Prostate Cancer Relapse Risk
From [jama.ama-assn.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[375]
Vitamin E and Prostate Cancer Moderate, daily doses of vitamin E ...
From [jama.ama-assn.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[376]
Vitamin E and Prostate Cancer Moderate, daily doses of vitamin E ...
From [jama.ama-assn.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[377]
New Virus Linked to Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
[378]
The Natural History of Clinically Localized Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
[379]
Radiation Dose Escalation as Treatment for Clinically Localized ...
From [jama.ama-assn.org] Last viewed: 07.09.2006
[380]
Use and Timing of Radiotherapy in High-Risk Prostate Cancer To the ...
From [jama.ama-assn.org] Last viewed: 07.09.2006
[381]
Screening Men for Prostate and Colorectal Cancer in the United States
From [jama.ama-assn.org] Last viewed: 07.09.2006
[382]
Detection of Prostate and Colon Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
[383]
Salvage Radiotherapy for Recurrent Prostate Cancer
From [jama.ama-assn.org] Last viewed: 07.09.2006
[384]
Uncertainty in Prostate Cancer Care
From [jama.ama-assn.org] Last viewed: 07.09.2006
[385]
030717 The Prevention of Prostate Cancer The Dilemma Continues
From [content.nejm.org] Last viewed: 07.09.2006
[386]
030717 The Prevention of Prostate Cancer The Dilemma Continues
From [content.nejm.org] Last viewed: 07.09.2006
[387]
PSA Velocity and Prostate Cancer
From [content.nejm.org] Last viewed: 07.09.2006
[388]
Prevention of Prostate Cancer with Finasteride
From [content.nejm.org] Last viewed: 07.09.2006
[389]
030717 The Prevention of Prostate Cancer The Dilemma Continues
From [content.nejm.org] Last viewed: 07.09.2006
[390]
Understanding prostate cancer
From [rsh.sagepub.com] Last viewed: 07.09.2006
Found 2058 documents
Page 13 of 69 Pages:
<< < 8 9 10 11 12 13 14 15 16 17 18 > >>
cancers
homepage
last week